Are you interested in developing new evaluation approaches for how challenge-based research and innovation projects can contribute to achieving missions on beating cancer? Join our team as a PhD candidate at the
Copernicus institute of Sustainable Development.
Your job The vacancy is part of the
National Growth Fund Oncode Accelerator and positioned within the Copernicus Institute’s Mission-oriented Innovation Policy Observatory, a transdisciplinary initiative for studying and enhancing ambitious endeavours that aim to address societal challenges such as missions on cancer and health and wellbeing.
The Copernicus Institute of Sustainable Development is looking for a PhD candidate who would like to join our interdisciplinary team to study new forms of monitoring and evaluation of challenge-based research and innovation projects to support societal missions on cancer. You will become part of the National Growth Fund programme
Oncode Accelerator, which aims to accelerate the development and clinical application of new cancer therapies to address unmet medical needs. Your position will also be embedded in the Copernicus Institute’s
Mission-oriented Innovation Policy Observatory, a transdisciplinary initiative for studying and enhancing ambitious endeavours to address societal challenges such as missions on cancer and health and wellbeing.
As a PhD candidate you will contribute to developing a theory of change and monitoring and evaluation approach to understand and assess the process of impact creation in large translational research projects such as Oncode Accelerator. You will particularly focus on how science and technology development in these projects contribute to shaping the Dutch and European health innovation system and addressing societal missions on beating cancer. This includes a focus on the role of clinical data infrastructures, in-vitro models such as organoids and artificial intelligence approaches for drug discovery. As part of the regulatory innovation workstream of the Oncode Accelerator programme, you will also consider how processes of regulatory and policy change are part of mission achievement. This involves active collaborations with the Utrecht Centre for Pharmaceutical Policy and Regulation and Dutch Medicines Evaluation Board.